74 related articles for article (PubMed ID: 20439144)
1. Isolation and identification of ester impurities in RG7128, an HCV polymerase inhibitor.
Chow J; Liu Y; Comstock K; Brandl M; Lin F; Li F; Sarma K; Alfredson T
J Pharm Biomed Anal; 2010 Nov; 53(3):710-6. PubMed ID: 20439144
[TBL] [Abstract][Full Text] [Related]
2. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
[TBL] [Abstract][Full Text] [Related]
3. Isolation and structural identification of an impurity in fluconazole bulk drug substance.
Dongre VG; Ghugare PD; Karmuse PP; Soudagar SR; Panda N; Kumar A
J Pharm Biomed Anal; 2007 Nov; 45(3):422-9. PubMed ID: 17706390
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of new impurities in rivastigmine.
Srinivasa Rao M; Rao SV; Srinivasa Rao DV; Bharathi Ch; Rajput P; Sharma HK
Pharmazie; 2010 May; 65(5):336-8. PubMed ID: 20503924
[TBL] [Abstract][Full Text] [Related]
5. Preparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MS.
Dongre VG; Karmuse PP; Ghugre PD; Salunke SM; Panda N; Kumar A
J Pharm Biomed Anal; 2006 Sep; 42(3):334-40. PubMed ID: 16757140
[TBL] [Abstract][Full Text] [Related]
6. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
[TBL] [Abstract][Full Text] [Related]
7. LC determination of glimepiride and its related impurities.
Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
[TBL] [Abstract][Full Text] [Related]
8. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
[TBL] [Abstract][Full Text] [Related]
9. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
Vuletić M; Cindrić M; Koruznjak JD
J Pharm Biomed Anal; 2005 Apr; 37(4):715-21. PubMed ID: 15797793
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
[TBL] [Abstract][Full Text] [Related]
12. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
[TBL] [Abstract][Full Text] [Related]
13. Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.
Zhou H; Tai Y; Sun C; Pan Y
J Pharm Biomed Anal; 2005 Feb; 37(1):97-107. PubMed ID: 15664748
[TBL] [Abstract][Full Text] [Related]
14. Isolation, structural elucidation and characterization of impurities in Cefdinir.
Rao KV; Rani A; Reddy AV; Bharathi CH; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 Mar; 43(4):1476-82. PubMed ID: 17174507
[TBL] [Abstract][Full Text] [Related]
15. Identification, isolation and characterization of potential degradation products in pioglitazone hydrochloride drug substance.
Ramulu K; Kumar TT; Krishna SR; Vasudev R; Kaviraj M; Rao BM; Rao NS
Pharmazie; 2010 Mar; 65(3):162-8. PubMed ID: 20383934
[TBL] [Abstract][Full Text] [Related]
16. Non-nucleoside inhibitors of the HCV polymerase.
Sarisky RT
J Antimicrob Chemother; 2004 Jul; 54(1):14-6. PubMed ID: 15190019
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product.
Mohan A; Hariharan M; Vikraman E; Subbaiah G; Venkataraman BR; Saravanan D
J Pharm Biomed Anal; 2008 May; 47(1):183-9. PubMed ID: 18313249
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of four process-related impurities in retigabine.
Wang X; Zhou H; Zheng J; Huang C; Liu W; Yu L; Zeng S
J Pharm Biomed Anal; 2012 Dec; 71():148-51. PubMed ID: 22954446
[TBL] [Abstract][Full Text] [Related]
19. Structural identification and characterization of impurities in ceftizoxime sodium.
Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
[TBL] [Abstract][Full Text] [Related]
20. Separation and characterization of clindamycin and related impurities in bulk drug by high-performance liquid chromatography-electrospray tandem mass spectrometry.
Zhou H; Zheng Z; Wu S; Tai Y; Cao X; Pan Y
J Pharm Biomed Anal; 2006 Jun; 41(4):1116-23. PubMed ID: 16617002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
